Epilepsy is a chronic brain disease, though it can be considered “resolved” under specific circumstances. Around 50 million people worldwide live with it, and for the majority, it requires long-term management with anti-seizure medications. The condition is defined not just by seizures themselves but by the brain’s enduring tendency to produce them.
Why Epilepsy Is Classified as a Disease
The International League Against Epilepsy (ILAE) defines epilepsy as a disease of the brain characterized by an enduring predisposition to generate seizures. That word “enduring” is key. A single seizure triggered by a high fever or alcohol withdrawal doesn’t qualify. To meet the diagnostic threshold, a person needs at least two unprovoked seizures more than 24 hours apart, or a single unprovoked seizure with a 60% or higher chance of another one within the next 10 years, or a recognized epilepsy syndrome.
The distinction between “disease” and “disorder” matters here. The ILAE deliberately upgraded the terminology from “disorder” to “disease” to reflect the seriousness of the condition and the lasting changes it involves in the brain. Epilepsy isn’t a temporary disruption. It reflects underlying alterations in how brain circuits function.
What Changes in the Brain
The chronic nature of epilepsy stems from physical and functional changes in brain tissue. In the most common adult form, temporal lobe epilepsy, these changes include loss of specific types of nerve cells, the formation of abnormal new connections between neurons, and chronic inflammation in brain tissue. Surviving nerve cells can rewire themselves in ways that make the brain more excitable over time, creating self-reinforcing circuits that are prone to producing seizures.
In some cases, the hippocampus (a structure critical for memory) shows visible shrinkage and scarring. These structural changes don’t reverse on their own, which is a major reason epilepsy persists even when seizures are temporarily controlled. The brain’s baseline state has shifted, and that shift is what makes the condition chronic rather than episodic.
Can Epilepsy Be “Resolved”?
Epilepsy can’t be cured in the traditional sense. The ILAE considered using the word “cure” but rejected it because it implies the risk of future seizures drops to the same level as someone who never had epilepsy. That essentially never happens. They also rejected “remission” because the public often misunderstands it. Instead, they settled on “resolved,” a term that means the person no longer has epilepsy but acknowledges it could return.
The criteria for resolution are strict. You must have been seizure-free for at least 10 years and off anti-seizure medication for at least 5 of those years. Alternatively, if you had an age-dependent epilepsy syndrome (certain childhood forms that are expected to end by a specific age), you’re considered resolved once you’ve passed that age. Even the authors of the 2014 ILAE definition acknowledged that the 10-year benchmark is one of the least evidence-supported parts of their framework.
What Happens When Medications Stop
The recurrence numbers tell the real story of epilepsy’s chronic nature. Among adults who stop taking anti-seizure medication after being seizure-free, roughly 39% experience a relapse. For children, the rate is lower but still significant at about 31%. Even among people with the most favorable prognosis, the relapse risk sits around 20% to 25%.
One study compared patients who continued medication to those who withdrew: at two years, the group that kept taking medication had a 22% relapse rate, while the withdrawal group hit 41%. The gap is stark enough that most neurologists approach medication withdrawal cautiously, even after years of seizure freedom. For many people, staying on medication indefinitely is the practical reality of living with epilepsy.
Mental Health and Cognitive Effects
Epilepsy’s chronic burden extends well beyond seizures. One in three people with epilepsy will receive a psychiatric diagnosis at some point, and the risk of developing any psychiatric condition is two to five times higher than in the general population. Depression is the most common, affecting about 23% of people with active epilepsy, a rate 2.7 times higher than average. Anxiety disorders follow closely at around 20%, with generalized anxiety being the most frequent type.
Psychosis is rarer but still significantly elevated, affecting about 5.6% of people with epilepsy overall and closer to 7% in those with temporal lobe epilepsy. In children and adolescents, ADHD affects roughly 33% and autism spectrum disorder about 21%, far exceeding rates in the general pediatric population.
These psychiatric conditions aren’t just quality-of-life issues. They’re associated with worse seizure control, more medication side effects, poorer cognitive function, and higher mortality. Depression in particular drives cognitive complaints, creates barriers to medication adherence, and increases the risk of substance misuse and suicide. The relationship runs both directions: the same brain changes that cause seizures also contribute to mood and cognitive problems, and living with an unpredictable condition compounds the psychological toll.
Long-Term Outlook
About 70% of people with epilepsy can achieve seizure freedom with the right medication, but achieving it and maintaining it are different things. Many of those people will stay on medication for years or decades. The remaining 30% have drug-resistant epilepsy, meaning seizures continue despite trying multiple treatments. For this group, options like surgery, nerve stimulation devices, or dietary therapies may help but rarely eliminate seizures entirely.
Globally, about 5 million people are newly diagnosed each year, with rates nearly three times higher in low- and middle-income countries (139 per 100,000 people) compared to high-income countries (49 per 100,000). Much of this disparity comes from limited access to treatment, meaning millions of people live with uncontrolled chronic epilepsy that could otherwise be managed. Even in the best-case scenarios, the underlying predisposition to seizures persists long after the last one occurs.